ArticleScientific reports2026
Hybrid diagnostic framework for bone cancer detection using deep learning and radiomics analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, bone cancer remains a big challenge in healthcare, early and accurate diagnosis is therefore key to achieving the required treatment outcomes. To this end, this research attempts to present a novel hybrid framework, i.e. TriMedNet, which works to classify bone cancer using multi-modal data sources. The diagnostic model is derived from integrating imaging data (MRI scans), unstructured clinical note texts and structured patient metrics (e.g., blood pressure, glucose levels). The three specialized branches of TriMedNet are; a Convolutional Neural Network (CNN) for image feature extraction, a Transformer based encoder Bidirectional Encoder Representations from Transformers (BERT) for text analysis, and fully connected dense layers for dealing with numerical data. The features extracted from each branch are fused and sent to the last classification layer for tumor diagnosis. The model was trained and evaluated on publicly available Roboflow dataset, with biopsy as well as blood test results. The accuracy of TriMedNet is 98.5%, precision 97.6%, recall 98.2, which effectively support the clinical decision making of bone cancer diagnosis. In research confirm that when multi-modal features are fused together, the diagnostic performance is greater than that of single modality approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.